Mehr: Clinical trials of favipiravir to treat COVID-19 launched in Iran

April 8, 2020  16:47

Clinical trials of antiviral drug favipiravir to treat coronavirus infection have been launched in Iran, Mehr reported.

Researchers at Shahid Beheshti Medical University have launched trials of the antiviral drug favipiravir at Masih Daneshvari Hospital.

This drug, as noted by the head of the clinic, Ali Akbar Velayati, first began to be produced in Iran after the country had a problem with access to medicines and medical equipment due to sanctions.

Earlier, Chinese experts claimed that the drug showed its effectiveness in use on 340 patients: it took them less time to recover and their lung function improved.

Follow Medicine on Facebook and Twitter

  • Video
  • Event calendar
  • Archive